Piroxicam

ANDA 74287, held by Watson Labs. Piroxicam.

As of Nov 15, 2026, ANDA 74287 (Piroxicam), held by Watson Labs, was first approved by FDA on May 16, 1996, with 1 approved supplement and 0 published complete response letters.

First approved: May 16, 1996
Supplements approved: 1
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 2 submissions below

Date	Submission	Status	Documents
May 16, 1996	Original application	Approved	None posted

Products

2 strengths and forms


Piroxicam10MG · capsule;oral	Piroxicam	Discontinued
Piroxicam20MG · capsule;oral	Piroxicam	Discontinued

All 2 submissions, including labeling and manufacturing supplements


Sep 8, 1998	Supplement 1Manufacturing	Approved	None posted
May 16, 1996	Original application	Approved	None posted

Identifiers

Application: ANDA 74287
Drugs@FDA: Overview at FDA
Company: Watson Laboratories

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters